Drug Shortage Means Pregnant Patients Get Delayed Care
As rates of congenital syphilis skyrocket, a severe shortage of the only antibiotic approved to treat syphilis in pregnant women is delaying care for pregnant patients.
A Step Forward for STI Testing: FDA Approves an At-Home Testing Option
For the first time, the Food and Drug Administration has given market authorization to an at-home test for chlamydia and gonorrhea.
Words Matter: Minimizing STI Stigma in Healthcare Settings
Talking about STIs is still considered taboo and conversations about sexual behavior are often uncomfortable—even in a healthcare setting. Learn ways to communicate without assumptions or judgment.
New Antibiotic Shows Promise in Treating Resistant Gonorrhea
A new antibiotic could give health care providers a much-needed new tool in the fight against antibiotic resistant strains of gonorrhea.
Syphilis Rates Surging in Newborns
Cases of infants born with syphilis have soared in recent years. New CDC data reveal that more than 3,700 babies were born with syphilis in 2022—more than 10 times the number born in 2012.
Shortage of Only Drug Approved to Treat Syphilis in Pregnant People
Treating syphilis during pregnancy can help both mother and child, but there is a shortage of Bicillin-L-A, the only antibiotic approved for this population.
People with Low Viral Loads Have Almost Zero Chance of Transmitting HIV Through Sex
A new meta-analysis of eight published studies found that the risk of sexual transmission of HIV is almost zero in people with low viral loads.
Update to PrEP Recommendations Include Long-Acting Shot
The USPSTF recently released updated recommendations on Pre-Exposure Prophylaxis for preventing the sexual transmission of HIV. The recommendations add additional medications, including a long-acting injectable.
August is National Immunization Awareness Month
Vaccinations are a great way to protect yourself, empower yourself, and to keep you — and your sex life — healthy and happy. Help us spread awareness about available vaccinations!
Cure Rates for Hepatitis C “Jarringly Low”
According to new data from the Centers for Disease Control and Prevention (CDC), only one in three adults in the U.S. infected with hepatitis C have been cured despite the introduction of direct-acting antivirals almost 10 years ago.